REFERENCE
Grima DT, Thompson MF, Sauriol L.Modelling cost effectiveness of insulin glargine for the treatment of type 1 and type 2 diabetes in Canada. PharmacoEconomics 25: 253-266, No. 3, 2007
Rights and permissions
About this article
Cite this article
ICERs favour long-term insulin glargine for diabetes. Pharmacoecon. Outcomes News 524, 7 (2007). https://doi.org/10.2165/00151234-200705240-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705240-00010